Design of ZnO-Drug Nanocarriers against the Main Protease of SARS-CoV-2 (COVID-19): An In Silico Assay

The treatment of coronavirus diseases (COVID-19) is a principal aim worldwide that is required restore public health in the population. To this end, we have been studied several kinds of de novo and repurposed drugs to investigate their ability to inhibit the replication of the virus which causes th...

Full description

Bibliographic Details
Main Authors: Erik Díaz-Cervantes, Cristal Zenteno-Zúñiga, Vicente Rodríguez-González, Faustino Aguilera-Granja
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Applied Nano
Subjects:
DFT
Online Access:https://www.mdpi.com/2673-3501/2/3/18